Literature DB >> 15345673

Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1.

Limor Shahrabani-Gargir1, Tej K Pandita, Haim Werner.   

Abstract

The IGF-I receptor (IGF-IR) has a central role in cell cycle progression as well as in the establishment of the transformed phenotype. Increased expression of the IGF-IR gene, in addition, is correlated with acquisition of radioresistance for cell killing. The ataxia-telangiectasia mutated (ATM) gene product has a pivotal role in coordinating the cellular response to DNA damage. The present study was aimed at testing the hypothesis that the ability of ATM to coordinate the DNA damage response that will lead to cell survival or, alternatively, to apoptosis depends, to a significant extent, on its capacity to control IGF-IR gene expression. The potential involvement of ATM in regulation of IGF-IR expression and function was investigated in isogenic cells with and without ATM function [AT22IJE-T/pEBS7 (ATM -/-) and ATM-corrected AT22IJE-T/YZ5 (ATM +/+) cells and 293 human embryonic kidney cells transfected with small interfering RNAs targeted to ATM]. In addition, the effect of ATM on IGF-IR expression was assessed in nonisogenic cells with ATM function (HFF + human telomerase reverse transcriptase) and without ATM function (GM5823 + human telomerase reverse transcriptase). Results obtained showed that IGF-IR gene expression and IGF-IR promoter activity were largely reduced in ATM -/- cells. Addition of the radiomimetic agent neocarzinostatin for 4 h, however, induced a significant increase in IGF-IR levels in cells without ATM function. In addition, IGF-I-induced IGF-IR and insulin receptor substrate-1 phosphorylation were greatly impaired in ATM-deficient cells. Furthermore, we identified zinc-finger transcription factors Sp1 and WT1 as potential mediators of the effect of ATM on IGF-IR gene expression. The present data suggests that the IGF-IR gene is a novel downstream target in an ATM-mediated DNA damage response pathway. Deregulated expression of the IGF-IR gene after ionizing radiation may be linked to genomic instability and enhanced transforming capacity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345673     DOI: 10.1210/en.2004-0613

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Involvement of human MOF in ATM function.

Authors:  Arun Gupta; Girdhar G Sharma; Charles S H Young; Manjula Agarwal; Edwin R Smith; Tanya T Paull; John C Lucchesi; Kum Kum Khanna; Thomas Ludwig; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

2.  ATM-dependent IGF-1 induction regulates secretory clusterin expression after DNA damage and in genetic instability.

Authors:  E M Goetz; B Shankar; Y Zou; J C Morales; X Luo; S Araki; R Bachoo; L D Mayo; D A Boothman
Journal:  Oncogene       Date:  2011-04-04       Impact factor: 9.867

Review 3.  Targeting the insulin growth factor receptor 1.

Authors:  Fernanda I Arnaldez; Lee J Helman
Journal:  Hematol Oncol Clin North Am       Date:  2012-02-28       Impact factor: 3.722

4.  Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression.

Authors:  Mike Y Chen; Aaron J Clark; Dana C Chan; Joy L Ware; Shawn E Holt; Archana Chidambaram; Helen L Fillmore; William C Broaddus
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

5.  Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.

Authors:  Jairam Vanamala; Lavanya Reddivari; Sridhar Radhakrishnan; Chris Tarver
Journal:  BMC Cancer       Date:  2010-05-26       Impact factor: 4.430

Review 6.  Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Authors:  Rongshi Li; Alan Pourpak; Stephan W Morris
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

7.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

Review 8.  Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Miles R Bryan; Aaron B Bowman
Journal:  Adv Neurobiol       Date:  2017

9.  Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein.

Authors:  Satoko Iwahori; Noriko Shirata; Yasushi Kawaguchi; Sandra K Weller; Yoshitaka Sato; Ayumi Kudoh; Sanae Nakayama; Hiroki Isomura; Tatsuya Tsurumi
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

10.  SIRT6 in DNA repair, metabolism and ageing.

Authors:  D B Lombard; B Schwer; F W Alt; R Mostoslavsky
Journal:  J Intern Med       Date:  2008-02       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.